Efficiency of peptide presentation by dendritic cells compared with other cell types: Implications for cross-priming

International Immunology

Volumn 18, Issue 12, 2006, Pages 1647-1654

  Zehn, Dietmar ^a,c   Cohen, Cyril J ^b   Reiter, Yoram ^b   Walden, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIBODY;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS PRESENTATION; DAUDI CELL; DENDRITIC CELL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA CELL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL LINE, TUMOR; CROSS-PRIMING; DENDRITIC CELLS; HLA-A ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDES; T-LYMPHOCYTES;

EID: 33845371760     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl098     Document Type: Article

References (18)

1. Miller, J. F., Kurts, C., Allison, J., Kosaka, H., Carbone, F. and Heath, W. R. 1998. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol. Rev. 165:267.
2. Binder, R. J., Han, D. K. and Srivastava, P. K. 2000. CD91: A receptor for heat shock protein gp96. Nat. Immunol. 1:151.
3. Shen, L. and Rock, K. L. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl Acad. Sci. USA 101:3035.
4. Norbury, C. C., Basta, S., Donohue, K. B. et al. 2004. CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304:1318.
5. Serna, A., Ramirez, M. C., Soukhanova, A. and Sigal, L. J. 2003. Cutting edge: Efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171:5668.
6. Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H. G. and Townsend, A. 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 21:2069.
7. Ortiz-Navarrete, V. and Hammerling, G. J. 1991. Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc. Natl Acad. Sci. USA 88:3594.
8. Smith, M. H. and Barber, B. H. 1990. The conformational flexibility of class I H-2 molecules as revealed by anti-peptide antibodies specific for intracytoplasmic determinants: Differential reactivity of beta 2-microglobulin "bound" and "free" H-2Kb heavy chains. Mol. Immunol. 27:169.
9. Cohen, C. J., Sarig, O., Yamano, Y., Tomaru, U., Jacobson, S. and Reiter, Y. 2003. Direct phenotypic analysis of human MHC class I antigen presentation: Visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies. J. Immunol. 170:4349.
10. Denkberg, G., Cohen, C. J., Lev, A., Chames, P., Hoogenboom, H. R. and Reiter, Y. 2002. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC-restricted T cell receptor-like specificity. Proc. Natl Acad. Sci. USA 99:9421.
11. Zehn, D., Cohen, C. J., Reiter, Y. and Walden, P. 2004. Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells. Eur. J. Immunol. 34:1551.
12. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
13. Amoscato, A. A., Prenovitz, D. A. and Lotze, M. T. 1998. Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. J. Immunol. 161:4023.
14. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
15. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
16. Belz, G. T., Behrens, G. M., Smith, C. M. et al. 2002. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance totissue-associatedantigens. J. Exp. Med. 196:1099.
17. den Haan, J. M., Lehar, S. M. and Bevan, M. J. 2000. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685.
18. Widmann, C., Maryanski, J. L., Romero, P. and Corradin, G. 1991. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol. 147:3745.